Information for Health Care Professionals
Print this Page

Depression Resources

Learn about treating depression with PRISTIQ

The following are depression resources that we hope you find useful to help further educate yourself and your family and friends about this common and treatable disease.

The appearance of external websites does not constitute endorsement by Pfizer Inc of the websites, or the information, products, or services contained therein. For other than authorized Pfizer activities or sites, Pfizer does not exercise any editorial control over the information you may find at these locations.

  • American Psychiatric Foundation - www.psychfoundation.org
    Committed to operating programs and funding initiatives that promote awareness of mental illnesses, the effectiveness of treatment, and the importance of early intervention.
  • Depression and Bipolar Support Alliance - www.ndmda.org
    A patient-directed organization whose purpose is to educate patients, families, and the public concerning the nature of depressive illness.
  • HealthyMinds.org - www.healthyminds.org
    Created by the American Psychiatric Association, the site provides information on psychiatric disorders such as depression and provides help locating a psychiatrist in your local area.
  • National Alliance on Mental Illness (formerly the National Alliance for the Mentally Ill) - www.nami.org
    A support, educational, and advocacy organization for people with mental illness and their families, with over 1,200 local affiliates. Local affiliates give guidance to finding treatment.
  • National Institute of Mental Health - www.nimh.nih.gov
    The largest scientific organization in the world dedicated to research focused on the understanding, treatment, and prevention of mental disorders and the promotion of mental health.
  • Mental Health America (formally the National Mental Health Association) - www.nmha.org
    An association that works with over 340 affiliates to promote mental health through advocacy, education, research, and services.

Important Safety Information for PRISTIQ

PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.

Suicidality and Antidepressant Drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.